Ocular hypotensive effect of tafluprost in latanoprost low-responder cynomolgus monkeys

Kurashima H., Asai Y., Aihara M., Ishida N., Nakamura M., Araie M.

2012
Journal of Glaucoma

View publication

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Research and Development Center, Santen Pharmaceutical Co., Ltd, Nara, Japan; Graduate School of Biological Sciences, Nara Institute of Science and Technology, Nara, Japan; Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan

Related Publications

Posterior Ciliary Artery Contraction by Bradykinin Receptor Subtypes and Implications for Retinal Blood Flow Dysfunction

Sharif NA, Ohia SE, Kulkarni-Chitnis M, Okolie A, Chaudhry SD, Njie-Mbye YF

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A 3-Year Prospective Study

Akagi T, Fukuchi T, Higashide T, Udagawa S, Ohkubo S, Sugiyama K, Tanihara H, Araie M, Tomita G, Matsumoto C, Tomidokoro A, Hangai M, Kawata H, Inai M, Tanaka Y; SVF Prospector Study Group.

Cost-utility analysis of latanoprost unidose cationic emulsion preservative-free versus latanoprost unidose in the treatment of open-angle glaucoma and ocular hypertension patients in Spain

Canut MI, García-Feijoo J, Larrosa-Poves JM, López-López F, Pazos M, Espinoza-Cámac N, Oyagüez I, Del Rio T, Rodríguez M.

View all Glaucoma publications